(Q24186696)

title

Nortriptyline for neuropathic pain in adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485407&resulttype=core&format=json

14 May 2020

0 references

1 reference

ChEBI release 2020-05-28

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485407&resulttype=core&format=json

14 May 2020

Dominic Aldington

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485407&resulttype=core&format=json

14 May 2020

1

Sheena Derry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485407&resulttype=core&format=json

14 May 2020

4

R Andrew Moore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485407&resulttype=core&format=json

Cochrane Database of Systematic Reviews

14 May 2020

publication date

8 January 2015

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485407&resulttype=core&format=json

14 May 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485407&resulttype=core&format=json

14 May 2020

page(s)

CD011209

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485407&resulttype=core&format=json

Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Prevalence of chronic pain with neuropathic characteristics in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Anticonvulsant drugs for migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Topical capsaicin (low concentration) for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Topical capsaicin (high concentration) for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Topical lidocaine for neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Sodium channel blockade may contribute to the analgesic efficacy of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Imipramine for neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Drugs for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Epidemiology and Clinical Features of Idiopathic Trigeminal Neuralgia and Glossopharyngeal Neuralgia: Similarities and Differences, Rochester, Minnesota, 1945-1984

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Incidence of facial pain in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Meta-analysis in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Brain imaging of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Pregabalin for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Numbers-needed-to-treat analyses--do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Amitriptyline for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Expect analgesic failure; pursue analgesic success

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Gabapentin for chronic neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Duloxetine use in chronic painful conditions--individual patient data responder analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Treatment of neuropathic pain: an overview of recent guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Neuropathic features of joint pain: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Pregabalin in fibromyalgia--responder analysis from individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Can neuroimaging studies identify pain endophenotypes in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Neuropathic pain: redefinition and a grading system for clinical and research purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Neuropathic pain in the general population: a systematic review of epidemiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Deconstructing the neuropathic pain phenotype to reveal neural mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

Antidepressants for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

A new definition of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011209.PUB2

The importance of quality of primary studies in producing unbiased systematic reviews

21 January 2018

1 reference

12 December 2020

Pharmacological treatment of fibromyalgia

1 reference

12 December 2020

Chronic pain: genes, plasticity, and phenotypes

1 reference

12 December 2020

Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy.

1 reference

12 December 2020

Topical lidocaine for neuropathic pain in adults

1 reference

12 December 2020

Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP Trial.

1 reference

12 December 2020

Patient-centered perspective on treatment outcomes in chronic pain

1 reference

12 December 2020

A randomized, within-patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain

1 reference

12 December 2020

10.1002/14651858.CD011209.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

3414770

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485407&resulttype=core&format=json

14 May 2020

3414770

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485407&resulttype=core&format=json

14 May 2020

PubMed publication ID

25569864

2 references

Consolidated OpenCitations Corpus – April 2017

3414770